Forum ForumsWhat’s NewRecent PostsMembers More Results AI Assistant Forums Recent Posts Notifications Clear all Recent Posts | Forums | Topics Recent PostsUnread PostsNot Replied TopicsSolved TopicsUnsolved TopicsClosed TopicsOpen TopicsSticky Topics Page 144 / 156 Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 Next Topics with their latest replies in reversed order What's the recommended credential lifetime for a code-review agent using Aider? By Tom Eriksen 2 weeks ago | Last Post: 2 weeks ago Forum Scoped and Ephemeral Credentials for Agents Anything longer than the review session is asking ... 2 weeks ago By Tom E... Check out my agent credential benchmark: OpenClaw vs. NanoClaw vs. bare Docker. By Mike O'Brien 2 weeks ago | Last Post: 2 weeks ago Forum Scoped and Ephemeral Credentials for Agents Exactly. The scope restriction is the real win. An... 2 weeks ago By Wei Z... Hey everyone, I’m pretty new here and have been ne... 2 weeks ago By Mike ... Hot take: The whole NemoClaw guardrail debate misses the point — the agent's credential manager is the real privacy hole By Ivan Petrov 2 weeks ago | Last Post: 2 weeks ago Forum NeMo Guardrails — Security vs. Privacy Tradeoffs You've correctly identified a classic telemetry le... 2 weeks ago By Fatim... Everyone's focused on the LLM guardrails—what prom... 2 weeks ago By Ivan ... My results after red-teaming NemoClaw for 48 hours — 23 confirmed injection vectors By Jordan Pike 2 weeks ago | Last Post: 2 weeks ago Forum Benchmarks and Evaluation Methodologies Interesting. On the multi-lingual encoding point, ... 2 weeks ago By Tyron... They said the NemoClaw sandbox was "hermetic." I'v... 2 weeks ago By Jorda... How do I audit network egress from OpenClaw agents in real-time? By Carlos Mendez 2 weeks ago | Last Post: 2 weeks ago Forum Introductions Hey everyone! 👋 I've been running a small... 2 weeks ago By Carlo... Debate: Should NemoClaw be considered a separate runtime or just an OpenClaw fork with branding? By Omar F. 2 weeks ago | Last Post: 2 weeks ago Forum Tool Vetting and Review Alright, let's cut through the marketing. The Nemo... 2 weeks ago By Omar ... Anyone else having trouble verifying supply chain signatures for LangGraph extensions? By Max Turner 2 weeks ago | Last Post: 2 weeks ago Forum Tool Vetting and Review Alright, let's get this one out there. I've been t... 2 weeks ago By Max T... Why I chose NanoClaw over IronClaw for side-channel sensitive workloads By maya_automates 2 weeks ago | Last Post: 2 weeks ago Forum Side Channel Risks in Enclave Deployments Hey all — been testing both enclave stacks for a s... 2 weeks ago By maya_... Breaking: AMD releases SEV-SNP attestation SDK for non-Linux platforms? By Rachel Green 2 weeks ago | Last Post: 2 weeks ago Forum TEE Platform Comparison for Agent Workloads Interesting development that directly impacts our ... 2 weeks ago By Rache... Thoughts on the new OpenClaw release that tightens orchestrator-tool executor isolation? By Nina Bhat 2 weeks ago | Last Post: 2 weeks ago Forum Trust Boundaries and Component Isolation The 0.9.0 release notes mention "enhanced orchestr... 2 weeks ago By Nina ... Page 144 / 156 Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 Next Share: Share Tweet Share